Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]
Phase 3 trial evaluating efficacy and safety of octreotide subcutaneous depot in patients with acromegaly has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
This entry reports the completion of a clinical trial studying peri-operative dynamics of the growth hormone axis in subjects with acromegal…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) [Phase 3]
PATHFNDR-2 is a Phase 3 study assessing the safety and efficacy of Paltusotine for acromegaly. Results were posted on January 13, 2026.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly [Phase 3]
This document covers a Phase 3 trial evaluating the safety and efficacy of paltusotine for acromegaly. Results were posted on 2026-01-13.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]
This Phase 3 trial evaluated the long-term safety of Octreotide Subcutaneous Depot in patients with acromegaly. The study sponsored by Camur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Reproducibility and Utility of OGTT in Acromegaly [NA]
A completed clinical trial evaluating the reproducibility and utility of the oral glucose tolerance test in acromegaly.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) [Phase 1]
Phase 1 study evaluating Debio 4126 in participants with acromegaly or functioning gastroenteropancreatic neuroendocrine tumors has been ter…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active Acromegaly [NA]
A completed clinical trial comparing ketogenic and Mediterranean diets in active acromegaly, evaluating metabolic and hormonal parameters.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: A Prospective Study of Outcome After Therapy for Acromegaly
A prospective study evaluating outcomes after therapy for acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Phase 1 Study of TE-8214 Solution in Healthy Volunteers [Phase 1]
A Phase 1 trial of TE-8214 Solution in healthy volunteers has completed. Acromegaly is listed as the condition of interest for the study.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Treatment Patterns and Treatment Outcomes for Acromegaly
This completed clinical trial update analyzes how acromegaly is treated in practice and the associated patient outcomes.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) [Phase 2]
This is a Phase 2 study (ACROBAT Evolve) assessing the safety and efficacy of Paltusotine for acromegaly; the trial completed and results we…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) [Phase 2]
A Phase 2 trial (ACROBAT Edge) evaluating paltusotine for acromegaly has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
A completed real-world study in China evaluating lanreotide Autogel for acromegaly.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: PegvisOMant and the Immune SystEm (PROMISE)
The PROMISE trial, sponsored by the University of Roma La Sapienza, studied pegvisomant in acromegaly with an emphasis on immune-system effe…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly
A completed clinical trial update from Ipsen studying participants’ experiences with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly [Phase 2]
Phase 2 study evaluating the safety, tolerability, and efficacy of IONIS-GHR-LRx in patients with acromegaly has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
A completed clinical trial evaluated acromegaly patients resistant to conventional doses of first-generation somatostatin ligands.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies [Phase 4]
Phase 4 expanded-access study update for pasireotide shows completed status with results posted, enabling access for eligible patients in No…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Effects of Sandostatin LAR® in Acromegaly [Phase 4]
This update reports the completion and results of a Phase 4 trial evaluating Sandostatin LAR in patients with acromegaly.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Octreotide Subcutaneous Depot for Acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands [Phase 2]
Extension study update for Ionis-GHR-LRx in acromegaly patients on long-acting somatostatin receptor ligands; Phase 2 completed.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Acromegaly Combination Treatment Study [NA]
A terminated clinical trial update for an acromegaly combination treatment study; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands [Phase 2]
Phase 2 clinical trial assessing safety, tolerability, and efficacy of IONIS-GHR-LRx in acromegaly patients on long-acting somatostatin rece…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly [Phase 3]
A Phase 3 trial comparing oral octreotide capsules with injectable somatostatin analogs in acromegaly has completed with results posted.